Department of Pharmacology & Toxicology, CARIM, University Maastricht, Maastricht, the Netherlands.
Acta Physiol (Oxf). 2009 Jun;196(2):231-7. doi: 10.1111/j.1748-1716.2008.01916.x. Epub 2008 Oct 23.
Transient angiotensin II receptor blockade (ARB) leads to prolonged blood pressure (BP) lowering, but the underlying mechanism remains uncertain. Long-term BP control is regulated by the medullary microcirculation with the pericyte as contractile cell. We hypothesize that the prolonged BP effect is caused by increased medullary blood flow (MBF) associated with structural alterations based on reduced medullary pericyte number.
Four-week-old spontaneously hypertensive rats (SHR) were treated for 4 weeks with losartan (SHR-Los: 20 mg kg(-1) day(-1)), hydralazine (SHR-Hyd: 15 mg kg(-1) day(-1)), losartan and pan-caspase inhibitor zVAD (SHR-Los + 1 mg kg(-1) day(-1) zVAD), losartan and glycogen synthase kinase-3beta (GSK) inhibitor valproate (SHR-Los + 10 mg kg(-1) day(-1) Val) or placebo. BP, MBF and pericyte number were determined under and after treatment (8 and 12 weeks). Apoptotic pericytes were determined with alpha-actin and TUNEL double staining. Sodium concentration was determined in renal medulla and urine.
Antihypertensive treatment equipotently reduced BP at 8 weeks of age. After drug withdrawal (12 weeks of age) BP reduction was restricted to SHR-Los (SHR-Los: 153 +/- 5, SHR-Hyd: 177 +/- 2, SHR: 184 +/- 3 mmHg). Simultaneously, MBF was increased and pericyte number reduced, while medullary and urinary sodium concentration increased. Transient ARB in combination with zVAD or valproate resulted in more medullary pericytes and higher BP (SHR-Los/zVAD: 164 +/- 7; SHR-Los/Val: 168 +/- 6 mmHg) compared with transient ARB alone.
After drug withdrawal, transient ARB leads to increased MBF and is associated with a reduction in medullary pericytes. This may be associated with pericyte apoptosis as anti-apoptosis during transient ARB increases pericyte number and BP.
短暂的血管紧张素Ⅱ受体阻断(ARB)可导致血压(BP)持续降低,但潜在机制尚不清楚。长期血压控制受髓质微循环调节,其中周细胞为收缩细胞。我们假设,延长的 BP 作用是由与结构改变相关的髓质血流量(MBF)增加引起的,这是基于减少的髓质周细胞数量。
4 周龄自发性高血压大鼠(SHR)接受洛沙坦(SHR-Los:20 mg/kg/天)、肼屈嗪(SHR-Hyd:15 mg/kg/天)、洛沙坦和泛半胱天冬酶抑制剂 zVAD(SHR-Los + 1 mg/kg/天 zVAD)、洛沙坦和糖原合酶激酶-3β(GSK)抑制剂丙戊酸钠(SHR-Los + 10 mg/kg/天 Val)治疗 4 周。在治疗下和治疗后(8 周和 12 周)测定 BP、MBF 和周细胞数量。用α-肌动蛋白和 TUNEL 双重染色法测定凋亡周细胞。测定肾髓质和尿液中的钠浓度。
抗高血压治疗在 8 周龄时等效降低 BP。停药后(12 周龄),BP 降低仅限于 SHR-Los(SHR-Los:153±5、SHR-Hyd:177±2、SHR:184±3 mmHg)。同时,MBF 增加,周细胞数量减少,而髓质和尿钠浓度增加。短暂的 ARB 与 zVAD 或丙戊酸钠联合使用会导致更多的髓质周细胞和更高的 BP(SHR-Los/zVAD:164±7;SHR-Los/Val:168±6 mmHg)与单纯短暂的 ARB 相比。
停药后,短暂的 ARB 可导致 MBF 增加,并与髓质周细胞减少有关。这可能与周细胞凋亡有关,因为在短暂的 ARB 期间抗凋亡可增加周细胞数量和 BP。